| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|
| Revenue | 19.55B | 18.34B | 17.59B | 17.16B | 16.63B |
| Cost of Revenue | 11.63B | 11.16B | 10.41B | 10.40B | 10.09B |
| Gross Profit | 7.92B | 7.18B | 7.17B | 6.77B | 6.55B |
| Operating Expenses | 5.49B | 4.66B | 4.38B | 4.05B | 4.42B |
| Selling, General & Admin | 4.28B | 3.63B | 3.56B | 3.24B | 3.59B |
| Research & Development | 1.21B | 1.03B | 816.00M | 810.00M | 833.00M |
| Other Operating Expenses | 431.00M | 67.00M | 59.00M | N/A | 1.00M |
| Operating Income | 2.44B | 2.52B | 2.79B | 2.72B | 2.12B |
| Other Expenses / Income | 442.00M | -10.00M | 80.00M | -10.00M | -33.00M |
| Before Tax Income | 2.36B | 2.51B | 2.88B | 2.71B | 2.09B |
| Income Tax Expenses | 743.00M | 563.00M | 600.00M | 652.00M | 410.00M |
| Net Income | 1.57B | 1.92B | 2.25B | 2.06B | 1.52B |
| Interest Expenses | 542.00M | 77.00M | 40.00M | 66.00M | 88.00M |
| Basic Shares Outstanding | 455.00M | 453.93M | 454.71M | 454.71M | 454.71M |
| Diluted Shares Outstanding | 458.00M | 453.93M | 454.71M | 454.71M | 454.71M |
| EBITDA | 3.51B | 3.22B | 3.54B | 3.41B | 2.84B |
| EBITDA Margin | 17.97% | 17.57% | 20.13% | 19.84% | 17.06% |
| EBIT | 2.85B | 2.56B | 2.89B | 2.78B | 2.02B |
| EBIT Margin | 14.59% | 13.94% | 16.42% | 16.17% | 12.16% |
| Financial Year End | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |